1. Home
  2. IFF vs BGNE Comparison

IFF vs BGNE Comparison

Compare IFF & BGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IFF
    SELLHOLDBUYas of 8 hours ago
  • BGNE
    SELLHOLDBUYas of 8 hours ago
  • Stock Information
  • Founded
  • IFF 1833
  • BGNE 2010
  • Country
  • IFF United States
  • BGNE Cayman Islands
  • Employees
  • IFF N/A
  • BGNE N/A
  • Industry
  • IFF Major Chemicals
  • BGNE Biotechnology: Pharmaceutical Preparations
  • Sector
  • IFF Industrials
  • BGNE Health Care
  • Exchange
  • IFF Nasdaq
  • BGNE Nasdaq
  • Market Cap
  • IFF 22.7B
  • BGNE 19.2B
  • IPO Year
  • IFF N/A
  • BGNE 2016
  • Fundamental
  • Price
  • IFF $84.78
  • BGNE $177.70
  • Analyst Decision
  • IFF Buy
  • BGNE Buy
  • Analyst Count
  • IFF 16
  • BGNE 8
  • Target Price
  • IFF $107.71
  • BGNE $253.69
  • AVG Volume (30 Days)
  • IFF 1.4M
  • BGNE 494.7K
  • Earning Date
  • IFF 02-18-2025
  • BGNE 11-12-2024
  • Dividend Yield
  • IFF 1.90%
  • BGNE N/A
  • EPS Growth
  • IFF N/A
  • BGNE N/A
  • EPS
  • IFF N/A
  • BGNE N/A
  • Revenue
  • IFF $11,416,000,000.00
  • BGNE $3,351,304,621.00
  • Revenue This Year
  • IFF $0.32
  • BGNE $969.39
  • Revenue Next Year
  • IFF N/A
  • BGNE $24.79
  • P/E Ratio
  • IFF N/A
  • BGNE N/A
  • Revenue Growth
  • IFF N/A
  • BGNE 50.22
  • 52 Week Low
  • IFF $72.94
  • BGNE $126.97
  • 52 Week High
  • IFF $106.77
  • BGNE $248.16
  • Technical
  • Relative Strength Index (RSI)
  • IFF 26.84
  • BGNE 37.39
  • Support Level
  • IFF $84.61
  • BGNE $170.99
  • Resistance Level
  • IFF $87.92
  • BGNE $180.00
  • Average True Range (ATR)
  • IFF 1.54
  • BGNE 5.72
  • MACD
  • IFF -0.06
  • BGNE -1.35
  • Stochastic Oscillator
  • IFF 13.62
  • BGNE 16.77

Stock Price Comparison Chart: IFF vs BGNE

IFF
BGNE
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober050100150200250300350400450IFF VS BGNE

About IFF International Flavors & Fragrances Inc.

International Flavors & Fragrances is the largest specialty ingredients producer globally. The company sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. The nourish segment, which generates roughly half of revenue, is a leading flavor producer and also sell texturants, plant-based proteins, and other ingredients. The health and biosciences business, which generates around one fourth of revenue, is a global leader in probiotics and enzymes. IFF is also one of the leading fragrance producers in the world.

About BGNE BeiGene Ltd.

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2023, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 50% of BeiGene's revenue.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use